Inhibrx, Inc. Common Stock
INBX
INBX was delisted on the 29th of May, 2024.
101 hedge funds and large institutions have $1.01B invested in Inhibrx, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 26 increasing their positions, 24 reducing their positions, and 4 closing their positions.
875% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 4
53% more funds holding
Funds holding: 66 → 101 (+35)
49% more capital invested
Capital invested by funds: $682M → $1.01B (+$333M)
8% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 24
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$21.1M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$17.3M |
| 3 |
State Street
Boston,
Massachusetts
|
+$15.8M |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$15M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$14.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$11.5M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$9.92M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
-$5.6M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$4.71M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$3.26M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $637 | -$23.9K | -598 | -4% |
|
|
SCM
102
Soleus Capital Management
Greenwich,
Connecticut
| – | -$3.26M | -97,979 | Closed |
|
103
Millennium Management
New York
| – | -$1.65M | -49,634 | Closed |
|
|
PCP
104
Proficio Capital Partners
Newton,
Massachusetts
| – | -$668K | -20,044 | Closed |
|
|
MFS
105
Mirabella Financial Services
London,
United Kingdom
| – | -$361K | -10,840 | Closed |
|
INBX Hedge Fund Activity: Q4 2021 in Review
101 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Inhibrx, Inc. Common Stock (INBX) for Q4 2021, worth a combined $1.01B — up 49% from $682M a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new INBX positions and 4 closed out — a net gain of 35 holders — while 26 added to existing stakes and 24 trimmed.
The largest buyer was Vanguard Group, adding an estimated $21.1M. The largest seller was Wellington Management Group, cutting an estimated $11.5M.
- 101 institutional investors held Inhibrx, Inc. Common Stock (INBX) as of Q4 2021, up from 66 in Q3 2021.
- Funds reported $1.01B of Inhibrx, Inc. Common Stock stock for Q4 2021, up 49% quarter-over-quarter.
- 39 funds opened new Inhibrx, Inc. Common Stock positions in Q4 2021 and 4 closed out, a net change of +35 holders.
- The largest Inhibrx, Inc. Common Stock buyer in Q4 2021 was Vanguard Group, an estimated $21.1M added.
- The largest Inhibrx, Inc. Common Stock seller in Q4 2021 was Wellington Management Group, an estimated $11.5M sold.
Based on aggregated 13F filings for Q4 2021.